Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study

Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study

Key messages What is already known on this topic Dexamethasone decreased day-28 mortality in the randomised controlled trial RECOVERY in patients admitted for COVID-19, including 74% who required oxygen and 16% invasive mechanical ventilation (iMV). Other trials targeting critically ill patients did...

Full description

Bibliographic Details
Main Authors: Matthieu Raymond, Aurélie Le Thuaut, Pierre Asfar, Cédric Darreau, Florian Reizine, Gwenhaël Colin, Charly Dano, Julien Lorber, Baptiste Hourmant, Agathe Delbove, Aurélien Frérou, Jean Morin, Pierre Yves Egreteau, Philippe Seguin, Jean Reignier, Jean-Baptiste Lascarrou, Emmanuel Canet
Format: Article
Language:English
Published: SpringerOpen 2022-10-01
Series:Annals of Intensive Care
Subjects:
COVID-19
Dexamethasone
Mortality
Intubation
Ventilator-associated pneumonia
Online Access:https://doi.org/10.1186/s13613-022-01074-w

Internet

https://doi.org/10.1186/s13613-022-01074-w

Similar Items